ALEMBIC PHARMACEUTICALS LTD. - 533573 - Closure of Trading Window
Closure of Trading window from 1st July, 2023 till 48 hours after the declaration of the Unaudited financial results for the quarter ended 30th June, 202330-06-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Closure of Trading Window
Closure of Trading window from 1st July, 2023 till 48 hours after the declaration of the Unaudited financial results for the quarter ended 30th June, 2023ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimations dated 29th June, 2023, received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s). We request you to kindly take the same on record.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 28th June, 2023 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholders(s) of the Company for issue of Duplicate Share Certificate(s).ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 25th June, 2023 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SESI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the notice published on 23rd June, 2023 in English. language in Economic Times and Indian Express, English Editions and in vernacular language in Financial Express, Gujarati Edition, informing the members inter alia about the schedule of 13th Annual General Meeting of the Company, dispatch of Annual Report for F.Y. 2022-23 and procedure for voting.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 23rd June, 2023 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Of Record Date For Payment Of Dividend On Equity Shares For The Financial Year Ended 31St March, 2023
Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the Company has fixed Friday, 28th July, 2023 as the Record Date for determining the entitlement of members of the Company to receive dividend for the financial year ended 31st March, 2023. The payment of dividend will be made on or from Friday, 8th August, 2023, upon the same being approved at the Annual General Meeting scheduled to be held on 4th August, 2023.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 21st June, 2023 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding approval of the request received for issue of duplicate Share Certificate(s) and issue of letter of confirmation in lieu of the physical share certificate to the registered shareholder(s) in accordance with the provisions of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Submission Of Notice Of 13Th Annual General Meeting Of The Company
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Notice of 13th Annual General Meeting of the Members of the Company scheduled to be held on Friday, the 4th August, 2023 at 3:00 p.m. IST through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM').ALEMBIC PHARMACEUTICALS LTD. - 533573 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the Annual Report of the Company for the financial year ended 31st March, 2023. We request you to kindly take the same on record.